Cara Therapeutics (CARA) option implied volatility bid into announces FDA approval of KORSUVA injection
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Up)Join SI Premium – FREE
Cara Therapeutics (NASDAQ: CARA) 30-day option implied volatility is at 193; compared to its 52-week range of 56 to 205 into announces FDA approval of KORSUVA injection.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PENN Entertainment (PENN) call put ratio 10 calls to 1 put with focus on April weekly 19.50 calls
- Capital One Financial (COF) call put ratio 1 call to 2 puts into quarter results and outlook
- Comcast (CMCSA) call put ratio 1 call to 2.7 puts into quarter results and outlook
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
